Epinephrine and levonordefrine are α1-adrenergic-receptor agonists. They delay the uptake of LAs into the vascular compartment and contribute to prolonged soft-tissue anesthesia, i.e., anesthesia of the lip and tongue, and associated functional deficits.45 Phentolamine mesylate, 0.4 mg in 1.7 mL cartridges (OraVerse™, Novalar Pharmaceuticals) is a non-selective α1-adrenergic-receptor antagonist. When injected at the site of LA administration, it shortens post-treatment duration of soft-tissue anesthesia.45
Studies concluded that phentolamine mesylate administered at the same volume and at the same site as a LA with a vasoconstrictor significantly and safely reduces the duration of soft-tissue anesthesia and associated functional deficits.46-48 However, its use is not approved by the FDA in children under the age of 6 years or in children who weigh less than 33 lbs. (15 kg). Clinicians should also consider the risks/benefits of reversal when a longer period of postoperative pain is anticipated.
Your session is about to expire. Do you want to continue logged in?
WARNING! You did not finish creating your certificate. Please click CONTINUE below to return to your previous page to complete the process. Failure to complete ALL the steps will result in a loss of this test score, and you will not receive credit for this course.